Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
Learn more: New microfluidics device can detect cancer cells in blood
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Artificial intelligence could help diagnose cancer with one spot of dried bloodon May 1, 2024 at 2:32 pm
Scientists in China have created a test using artificial intelligence that can detect cancer using one spot of dried blood.
- One-two punch treatment delivers blood cancer knockouton May 1, 2024 at 12:49 pm
A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML), one of the most common types of blood cancers. A new study has ...
- Researchers identify biomarkers in blood to predict liver canceron May 1, 2024 at 11:19 am
Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for ...
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
a laboratory head in WEHI's Blood Cells and Blood Cancer division, said. "It is these two drugs, working in tandem, that led to the highly effective killing of AML cancer cells in our lab-based tests, ...
- Prostate cancer survivor sheds light on common stigmason May 1, 2024 at 6:01 am
“Because symptoms often don't appear before the cancer is at a more advanced stage, we need to be much louder about prostate cancer awareness and utilizing early detection as the first line of defense ...
- This Bathroom Issue Is a Common Sign of Colon Cancer, According to a GI Docon May 1, 2024 at 3:25 am
In fact, by the time someone does flag blood in the stool, it may no longer be an "early symptom" of colon cancer. "Blood in the stool is a relatively late sign of colorectal cancer and does not ...
- Dallas’ Breakthrough Blood Test for Canceron April 30, 2024 at 7:12 pm
A North Dallas diagnostic firm may be on the verge of revolutionizing the cancer screening process. Cancer Check Labs has developed a technology that can screen 40ml of blood and detect the growth of ...
- AI tool may help detect cancer in a few minutes with a drop of bloodon April 29, 2024 at 7:57 am
An AI-powered tool may be able to detect pancreatic, gastric, or colorectal cancer with a sensitivity of 82–100% and takes just a few minutes, a new study indicates.
- New blood test shows promise in early detection of ovarian canceron April 28, 2024 at 7:28 pm
A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian cancer, potentially allowing diagnosis through a simple blood test.
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
via Bing News